Delphine Reitter's research while affiliated with Hôpital Henri Mondor (Hôpitaux Universitaires Henri Mondor) and other places

Publications (2)

Article
Background Because of comorbidities and polypharmacy, older patients with cancer have a greater risk of iatrogenic events. We aimed to characterize potential drug-drug interactions (PDIs) and the risk of unplanned hospitalization in older patients with cancer treated with antineoplastic agents (ANAs). Methods We analyzed all older patients (≥70 y...

Citations

... The contributing risk factors for DDIs in oncology patients include genetics, poly pharmacy, long hospitalizations, comorbid conditions such as cardiac, renal or hepatic complications and advanced age [11,12]. Another important therapeutic challenge is tyrosine kinase inhibitors (TKI) mediated OATP1B1 or OATP1B3 inhibition that potentially cause DDIs influencing drug pharmacokinetic feature [13]. ...